Difference between revisions of "Team:UCC Ireland"
| Line 28: | Line 28: | ||
<!-- Latest compiled and minified JavaScript --> | <!-- Latest compiled and minified JavaScript --> | ||
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha384-Tc5IQib027qvyjSMfHjOMaLkfuWVxZxUPnCJA7l2mCWNIpG9mGCD8wGNIcPD7Txa" crossorigin="anonymous"></script> | <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha384-Tc5IQib027qvyjSMfHjOMaLkfuWVxZxUPnCJA7l2mCWNIpG9mGCD8wGNIcPD7Txa" crossorigin="anonymous"></script> | ||
| + | |||
| + | <link rel="stylesheet" href="https://2016.igem.org/2016.igem.org/Team:UCC_Ireland/CSS" /> | ||
Revision as of 11:56, 5 September 2016
UCC iGEM
El Galactios
Our Project:
Lactococcus lactis is a safe gram positive bacterium that is highly amenable to genetic manipulation. It is possible to build L. lactis strains that can deliver proteins to the immune system to precisely influence the host immune response. We intend to build synthetic L. lactis strains which express tumor-specific antigens and which can be delivered orally to patients to boost cancer-specific immunity.
